Advertisement
U.S. Markets open in 1 hr 43 mins

ViaDerma, Inc. (VDRM)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
0.0050-0.0001 (-1.96%)
At close: 01:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0051
Open0.0052
Bid0.0050 x 0
Ask0.0054 x 0
Day's Range0.0050 - 0.0052
52 Week Range0.0030 - 0.0160
Volume20,000
Avg. Volume1,652,856
Market Cap6.169M
Beta (5Y Monthly)-0.40
PE Ratio (TTM)0.04
EPS (TTM)0.1400
Earnings DateDec 16, 2024 - Dec 31, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth

    LOS ANGELES, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, announced its financial results for the second quarter and six-month period ending June 30, 2024. The company delivered a strong financial performance with notable revenue consistency, positive net income, and a robust increase in cash reserves. Financial Highlights for Q2 2024: Revenue: ViaDerma maintained steady revenues of $300,191 for the

  • GlobeNewswire

    ViaDerma Completes First Shipment of 500,000 Units to Nigeria

    A second shipment of 500,000 units is expected to be made by the end of OctoberLOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to announce the successful completion of its first shipment of 500,000 units of its flagship product, a tetracycline based topical antibiotic to Nigeria. The shipment was sent out as planned before the end of August 2024. This miles